EMEA (Europe, Middle East and Africa) Neuromodulation Devices Market Report 2017

December 2017 | 109 pages | ID: E6ACE6CC0ADEN
QYResearch

Abstracts

In this report, the EMEA Neuromodulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Neuromodulation Devices for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neuromodulation Devices market competition by top manufacturers/players, with Neuromodulation Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Medtronic
• Boston Scientific Corporation
• St.Jude Medical
• Synapse Biomedical
• Nevro
• Neurosigma
• Neuropace
• Neuronetics
• Cyberonics
• BioControl Medical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Deep Brain Stimulation (DBS) Systems
• Spinal Cord Stimulator (SCS) Systems
• Diaphragm Pacing System (DPS)
• Respiratory Electrical Stimulation (RES)
• Vagus Nerve Stimulation (VNS)
• Gastric Electrical Stimulation (GES)
• Transcranial Magnetic Stimulation (TMS)
• Transcutaneous Electrical Nerve Stimulation (TENS)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Chronic Pain
• Parkinson's Disease
• Urine Incontinence
• Epilepsy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Neuromodulation Devices Market Report 2017

1 NEUROMODULATION DEVICES OVERVIEW

1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Classification of Neuromodulation Devices
  1.2.1 EMEA Neuromodulation Devices Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Neuromodulation Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Deep Brain Stimulation (DBS) Systems
  1.2.4 Spinal Cord Stimulator (SCS) Systems
  1.2.5 Diaphragm Pacing System (DPS)
  1.2.6 Respiratory Electrical Stimulation (RES)
  1.2.7 Vagus Nerve Stimulation (VNS)
  1.2.8 Gastric Electrical Stimulation (GES)
  1.2.9 Transcranial Magnetic Stimulation (TMS)
  1.2.10 Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 EMEA Neuromodulation Devices Market by Application/End Users
  1.3.1 EMEA Neuromodulation Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Chronic Pain
  1.3.3 Parkinson's Disease
  1.3.4 Urine Incontinence
  1.3.5 Epilepsy
  1.3.6 Others
1.4 EMEA Neuromodulation Devices Market by Region
  1.4.1 EMEA Neuromodulation Devices Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Neuromodulation Devices (2012-2022)
  1.5.1 EMEA Neuromodulation Devices Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Neuromodulation Devices Revenue and Growth Rate (2012-2022)

2 EMEA NEUROMODULATION DEVICES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Neuromodulation Devices Market Competition by Players/Manufacturers
  2.1.1 EMEA Neuromodulation Devices Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Neuromodulation Devices Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Neuromodulation Devices Sale Price by Players (2012-2017)
2.2 EMEA Neuromodulation Devices (Volume and Value) by Type/Product Category
  2.2.1 EMEA Neuromodulation Devices Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Neuromodulation Devices Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Neuromodulation Devices Sale Price by Type (2012-2017)
2.3 EMEA Neuromodulation Devices (Volume) by Application
2.4 EMEA Neuromodulation Devices (Volume and Value) by Region
  2.4.1 EMEA Neuromodulation Devices Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Neuromodulation Devices Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Neuromodulation Devices Sales Price by Region (2012-2017)

3 EUROPE NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Neuromodulation Devices Sales and Value (2012-2017)
  3.1.1 Europe Neuromodulation Devices Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Neuromodulation Devices Revenue and Growth Rate (2012-2017)
3.2 Europe Neuromodulation Devices Sales and Market Share by Type
3.3 Europe Neuromodulation Devices Sales and Market Share by Application
3.4 Europe Neuromodulation Devices Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Neuromodulation Devices Sales Volume by Countries (2012-2017)
  3.4.2 Europe Neuromodulation Devices Revenue by Countries (2012-2017)
  3.4.3 Germany Neuromodulation Devices Sales and Growth Rate (2012-2017)
  3.4.4 France Neuromodulation Devices Sales and Growth Rate (2012-2017)
  3.4.5 UK Neuromodulation Devices Sales and Growth Rate (2012-2017)
  3.4.6 Russia Neuromodulation Devices Sales and Growth Rate (2012-2017)
  3.4.7 Italy Neuromodulation Devices Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Neuromodulation Devices Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Neuromodulation Devices Sales and Value (2012-2017)
  4.1.1 Middle East Neuromodulation Devices Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Neuromodulation Devices Revenue and Growth Rate (2012-2017)
4.2 Middle East Neuromodulation Devices Sales and Market Share by Type
4.3 Middle East Neuromodulation Devices Sales and Market Share by Application
4.4 Middle East Neuromodulation Devices Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Neuromodulation Devices Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Neuromodulation Devices Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Neuromodulation Devices Sales and Growth Rate (2012-2017)
  4.4.4 Israel Neuromodulation Devices Sales and Growth Rate (2012-2017)
  4.4.5 UAE Neuromodulation Devices Sales and Growth Rate (2012-2017)
  4.4.6 Iran Neuromodulation Devices Sales and Growth Rate (2012-2017)

5 AFRICA NEUROMODULATION DEVICES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Neuromodulation Devices Sales and Value (2012-2017)
  5.1.1 Africa Neuromodulation Devices Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Neuromodulation Devices Revenue and Growth Rate (2012-2017)
5.2 Africa Neuromodulation Devices Sales and Market Share by Type
5.3 Africa Neuromodulation Devices Sales and Market Share by Application
5.4 Africa Neuromodulation Devices Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Neuromodulation Devices Sales Volume by Countries (2012-2017)
  5.4.2 Africa Neuromodulation Devices Revenue by Countries (2012-2017)
  5.4.3 South Africa Neuromodulation Devices Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Neuromodulation Devices Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Neuromodulation Devices Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Neuromodulation Devices Sales and Growth Rate (2012-2017)

6 EMEA NEUROMODULATION DEVICES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Medtronic
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuromodulation Devices Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boston Scientific Corporation
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Neuromodulation Devices Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 St.Jude Medical
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Neuromodulation Devices Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 St.Jude Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Synapse Biomedical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Neuromodulation Devices Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Nevro
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Neuromodulation Devices Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Neurosigma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Neuromodulation Devices Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Neurosigma Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Neuropace
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Neuromodulation Devices Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Neuropace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Neuronetics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Neuromodulation Devices Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Neuronetics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Cyberonics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Neuromodulation Devices Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Cyberonics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 BioControl Medical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Neuromodulation Devices Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 NEUROMODULATION DEVICES MANUFACTURING COST ANALYSIS

7.1 Neuromodulation Devices Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuromodulation Devices

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuromodulation Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NEUROMODULATION DEVICES MARKET FORECAST (2017-2022)

11.1 EMEA Neuromodulation Devices Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Neuromodulation Devices Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Neuromodulation Devices Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Neuromodulation Devices Price and Trend Forecast (2017-2022)
11.2 EMEA Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Neuromodulation Devices Sales Forecast by Type (2017-2022)
11.7 EMEA Neuromodulation Devices Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neuromodulation Devices
Figure EMEA Neuromodulation Devices Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Neuromodulation Devices Sales Volume Market Share by Type (Product Category) in 2016
Figure Deep Brain Stimulation (DBS) Systems Product Picture
Figure Spinal Cord Stimulator (SCS) Systems Product Picture
Figure Diaphragm Pacing System (DPS) Product Picture
Figure Respiratory Electrical Stimulation (RES) Product Picture
Figure Vagus Nerve Stimulation (VNS) Product Picture
Figure Gastric Electrical Stimulation (GES) Product Picture
Figure Transcranial Magnetic Stimulation (TMS) Product Picture
Figure Transcutaneous Electrical Nerve Stimulation (TENS) Product Picture
Figure EMEA Neuromodulation Devices Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Neuromodulation Devices by Application in 2016
Figure Chronic Pain Examples
Table Key Downstream Customer in Chronic Pain
Figure Parkinson's Disease Examples
Table Key Downstream Customer in Parkinson's Disease
Figure Urine Incontinence Examples
Table Key Downstream Customer in Urine Incontinence
Figure Epilepsy Examples
Table Key Downstream Customer in Epilepsy
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Neuromodulation Devices Market Size (Million USD) by Region (2012-2022)
Figure Europe Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neuromodulation Devices Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Neuromodulation Devices Revenue (Million USD) Status and Forecast by Countries
Figure Africa Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Neuromodulation Devices Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Neuromodulation Devices Sales Volume and Growth Rate (2012-2022)
Figure EMEA Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Neuromodulation Devices Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Neuromodulation Devices Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Neuromodulation Devices Sales Share by Players (2012-2017)
Figure 2016 Neuromodulation Devices Sales Share by Players
Figure 2017 Neuromodulation Devices Sales Share by Players
Figure EMEA Neuromodulation Devices Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Neuromodulation Devices Revenue (Million USD) by Players (2012-2017)
Table EMEA Neuromodulation Devices Revenue Share by Players (2012-2017)
Table 2016 EMEA Neuromodulation Devices Revenue Share by Players
Table 2017 EMEA Neuromodulation Devices Revenue Share by Players
Table EMEA Neuromodulation Devices Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Neuromodulation Devices Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Neuromodulation Devices Sales Share by Type (2012-2017)
Figure Sales Market Share of Neuromodulation Devices by Type (2012-2017)
Figure EMEA Neuromodulation Devices Sales Market Share by Type (2012-2017)
Table EMEA Neuromodulation Devices Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Neuromodulation Devices Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neuromodulation Devices by Type in 2016
Table EMEA Neuromodulation Devices Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Neuromodulation Devices Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Neuromodulation Devices Sales Share by Application (2012-2017)
Figure Sales Market Share of Neuromodulation Devices by Application (2012-2017)
Figure EMEA Neuromodulation Devices Sales Market Share by Application in 2016
Table EMEA Neuromodulation Devices Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Neuromodulation Devices Sales Share by Region (2012-2017)
Figure Sales Market Share of Neuromodulation Devices by Region (2012-2017)
Figure EMEA Neuromodulation Devices Sales Market Share in 2016
Table EMEA Neuromodulation Devices Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Neuromodulation Devices Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Neuromodulation Devices by Region (2012-2017)
Figure EMEA Neuromodulation Devices Revenue Market Share Regions in 2016
Table EMEA Neuromodulation Devices Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Neuromodulation Devices Revenue and Growth Rate (2012-2017)
Table Europe Neuromodulation Devices Sales (K Units) by Type (2012-2017)
Table Europe Neuromodulation Devices Market Share by Type (2012-2017)
Figure Europe Neuromodulation Devices Market Share by Type in 2016
Table Europe Neuromodulation Devices Sales (K Units) by Application (2012-2017)
Table Europe Neuromodulation Devices Market Share by Application (2012-2017)
Figure Europe Neuromodulation Devices Market Share by Application in 2016
Table Europe Neuromodulation Devices Sales (K Units) by Countries (2012-2017)
Table Europe Neuromodulation Devices Sales Market Share by Countries (2012-2017)
Figure Europe Neuromodulation Devices Sales Market Share by Countries (2012-2017)
Figure Europe Neuromodulation Devices Sales Market Share by Countries in 2016
Table Europe Neuromodulation Devices Revenue (Million USD) by Countries (2012-2017)
Table Europe Neuromodulation Devices Revenue Market Share by Countries (2012-2017)
Figure Europe Neuromodulation Devices Revenue Market Share by Countries (2012-2017)
Figure Europe Neuromodulation Devices Revenue Market Share by Countries in 2016
Figure Germany Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure France Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure UK Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Neuromodulation Devices Sales (K Units) by Type (2012-2017)
Table Middle East Neuromodulation Devices Market Share by Type (2012-2017)
Figure Middle East Neuromodulation Devices Market Share by Type (2012-2017)
Table Middle East Neuromodulation Devices Sales (K Units) by Applications (2012-2017)
Table Middle East Neuromodulation Devices Market Share by Applications (2012-2017)
Figure Middle East Neuromodulation Devices Sales Market Share by Application in 2016
Table Middle East Neuromodulation Devices Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Neuromodulation Devices Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Neuromodulation Devices Sales Volume Market Share by Countries in 2016
Table Middle East Neuromodulation Devices Revenue (Million USD) by Countries (2012-2017)
Table Middle East Neuromodulation Devices Revenue Market Share by Countries (2012-2017)
Figure Middle East Neuromodulation Devices Revenue Market Share by Countries (2012-2017)
Figure Middle East Neuromodulation Devices Revenue Market Share by Countries in 2016
Figure Saudi Arabia Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Neuromodulation Devices Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Neuromodulation Devices Sales (K Units) by Type (2012-2017)
Table Africa Neuromodulation Devices Sales Market Share by Type (2012-2017)
Figure Africa Neuromodulation Devices Sales Market Share by Type (2012-2017)
Figure Africa Neuromodulation Devices Sales Market Share by Type in 2016
Table Africa Neuromodulation Devices Sales (K Units) by Application (2012-2017)
Table Africa Neuromodulation Devices Sales Market Share by Application (2012-2017)
Figure Africa Neuromodulation Devices Sales Market Share by Application (2012-2017)
Table Africa Neuromodulation Devices Sales Volume (K Units) by Countries (2012-2017)
Table Africa Neuromodulation Devices Sales Market Share by Countries (2012-2017)
Figure Africa Neuromodulation Devices Sales Market Share by Countries (2012-2017)
Figure Africa Neuromodulation Devices Sales Market Share by Countries in 2016
Table Africa Neuromodulation Devices Revenue (Million USD) by Countries (2012-2017)
Table Africa Neuromodulation Devices Revenue Market Share by Countries (2012-2017)
Figure Africa Neuromodulation Devices Revenue Market Share by Countries (2012-2017)
Figure Africa Neuromodulation Devices Revenue Market Share by Countries in 2016
Figure South Africa Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Table Medtronic Neuromodulation Devices Basic Information List
Table Medtronic Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Medtronic Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Boston Scientific Corporation Neuromodulation Devices Basic Information List
Table Boston Scientific Corporation Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Corporation Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Boston Scientific Corporation Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Boston Scientific Corporation Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table St.Jude Medical Neuromodulation Devices Basic Information List
Table St.Jude Medical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure St.Jude Medical Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure St.Jude Medical Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure St.Jude Medical Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Synapse Biomedical Neuromodulation Devices Basic Information List
Table Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synapse Biomedical Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Synapse Biomedical Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Synapse Biomedical Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Nevro Neuromodulation Devices Basic Information List
Table Nevro Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nevro Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Nevro Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Nevro Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Neurosigma Neuromodulation Devices Basic Information List
Table Neurosigma Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neurosigma Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Neurosigma Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Neurosigma Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Neuropace Neuromodulation Devices Basic Information List
Table Neuropace Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neuropace Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Neuropace Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Neuropace Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Neuronetics Neuromodulation Devices Basic Information List
Table Neuronetics Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neuronetics Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Neuronetics Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Neuronetics Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Cyberonics Neuromodulation Devices Basic Information List
Table Cyberonics Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cyberonics Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure Cyberonics Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure Cyberonics Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table BioControl Medical Neuromodulation Devices Basic Information List
Table BioControl Medical Neuromodulation Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioControl Medical Neuromodulation Devices Sales (K Units) and Growth Rate (2012-2017)
Figure BioControl Medical Neuromodulation Devices Sales Market Share in EMEA (2012-2017)
Figure BioControl Medical Neuromodulation Devices Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromodulation Devices
Figure Manufacturing Process Analysis of Neuromodulation Devices
Figure Neuromodulation Devices Industrial Chain Analysis
Table Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2016
Table Major Buyers of Neuromodulation Devices
Table Distributors/Traders List
Figure EMEA Neuromodulation Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Neuromodulation Devices Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Neuromodulation Devices Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Neuromodulation Devices Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Neuromodulation Devices Sales Market Share Forecast by Region (2017-2022)
Table EMEA Neuromodulation Devices Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Neuromodulation Devices Revenue Market Share Forecast by Region (2017-2022)
Table Europe Neuromodulation Devices Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Neuromodulation Devices Sales Market Share Forecast by Countries (2017-2022)
Table Europe Neuromodulation Devices Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Neuromodulation Devices Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Neuromodulation Devices Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Neuromodulation Devices Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Neuromodulation Devices Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Neuromodulation Devices Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Neuromodulation Devices Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Neuromodulation Devices Sales Market Share Forecast by Countries (2017-2022)
Table Africa Neuromodulation Devices Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Neuromodulation Devices Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Neuromodulation Devices Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Neuromodulation Devices Sales Market Share Forecast by Type (2017-2022)
Table EMEA Neuromodulation Devices Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Neuromodulation Devices Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources